{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:38:02Z","timestamp":1794667082147,"version":"4.9.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ejmech.2022.114788","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T11:46:14Z","timestamp":1664279174000},"page":"114788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Design and synthesis of functionalized 4-aryl-Catechol derivatives as new antiinflammtory agents with in vivo efficacy"],"prefix":"10.1016","volume":"243","author":[{"given":"Ferdinando","family":"Bruno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Krauth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohamed","family":"Nabavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Temml","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florinda","family":"Fratianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Spaziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena","family":"Nazzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorita","family":"Roviezzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroon","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Preziosa","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"D'Agostino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Werz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Filosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ejmech.2022.114788_bib1","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/s41589-020-0544-7","article-title":"Structural and mechanistic insights into 5-lipoxygenase inhibition by natural products","volume":"16","author":"Gilbert","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2022.114788_bib2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2147\/JIR.S278514","article-title":"Overview on the discovery and development of anti-inflammatory drugs: should the focus be on synthesis or degradation of PGE2?","volume":"14","author":"Mahesh","year":"2021","journal-title":"J. Inflamm. Res."},{"issue":"18","key":"10.1016\/j.ejmech.2022.114788_bib3","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.3390\/ijms20184367","article-title":"Animal models of inflammation for screening of anti-inflammatory drugs: implications for the discovery and development of phytopharmaceuticals","volume":"20","author":"Patil","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2022.114788_bib4","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ejmech.2019.06.034","article-title":"Human disorders associated with inflammation and the evolving role of natural products to overcome","volume":"179","author":"Kishore","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2022.114788_bib5","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cell.2010.03.006","article-title":"Inflammation 2010: new adventures of an old flame","volume":"140","author":"Medzhitov","year":"2010","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ejmech.2022.114788_bib6","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2010.02.029","article-title":"Nonresolving inflammation","volume":"140","author":"Nathan","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2022.114788_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114759","article-title":"Untangling the web of 5-lipoxygenase-derived products from a molecular and structural perspective: the battle between pro- and anti-inflammatory lipid mediators","volume":"193","author":"Gilbert","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"18","key":"10.1016\/j.ejmech.2022.114788_bib8","doi-asserted-by":"crossref","first-page":"6637","DOI":"10.3390\/ijms21186637","article-title":"Roles of specialized pro-resolving lipid mediators in autophagy and inflammation","volume":"10;21","author":"Recchiuti","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2022.114788_bib9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fimmu.2018.00038","article-title":"Bioactive lipids and chronic inflammation: managing the fire within","volume":"9","author":"Chiurchiu","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114788_bib10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1042\/EBC20190083","article-title":"Eicosanoids","volume":"64","author":"Calder","year":"2020","journal-title":"Essays Biochem."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114788_bib11","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/EBC20200018","article-title":"Specialized pro-resolving mediator network: an update on production and actions","volume":"64","author":"Chiang","year":"2020","journal-title":"Essays Biochem."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114788_bib12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1042\/EBC20190082","article-title":"Oxidation of polyunsaturated fatty acids to produce lipid mediators","volume":"64","author":"Christie Harwood Jl","year":"2020","journal-title":"Essays Biochem."},{"issue":"18","key":"10.1016\/j.ejmech.2022.114788_bib13","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJMra071371","article-title":"Leukotrienes","volume":"357","author":"Peters-Golden","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.ejmech.2022.114788_bib14","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.tibs.2007.06.002","article-title":"5-Lipoxygenase: regulation of expression and enzyme activity","volume":"32","author":"Radmark","year":"2007","journal-title":"Trends Biochem. Sci."},{"issue":"40","key":"10.1016\/j.ejmech.2022.114788_bib15","doi-asserted-by":"crossref","first-page":"28264","DOI":"10.1074\/jbc.274.40.28264","article-title":"Differential metabolism of exogenous and endogenous arachidonic acid in human neutrophils","volume":"274","author":"Sala","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"2\u20133","key":"10.1016\/j.ejmech.2022.114788_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0952-3278(03)00070-X","article-title":"5-lipoxygenase and FLAP","volume":"69","author":"Peters-Golden","year":"2003","journal-title":"Prostagl. Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.ejmech.2022.114788_bib17","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1172\/JCI97945","article-title":"Leukotriene biosynthetic enzymes as therapeutic targets","volume":"128","author":"Haeggstr\u00f6m","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114788_bib18","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/13543776.2017.1276568","article-title":"Novel leukotriene biosynthesis inhibitors (2012-2016) as anti-inflammatory agents","volume":"27","author":"Werz","year":"2017","journal-title":"Expert Opin. Ther. Pat."},{"issue":"6","key":"10.1016\/j.ejmech.2022.114788_bib19","first-page":"689","article-title":"Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitis. Clinical and experimental allergy: journal of the","volume":"36","author":"Peters-Golden","year":"2006","journal-title":"British Society for Allergy and Clinical Immunology"},{"issue":"3","key":"10.1016\/j.ejmech.2022.114788_bib20","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.pharmthera.2006.05.009","article-title":"Therapeutic options for 5-lipoxygenase inhibitors","volume":"112","author":"Werz","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2022.114788_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejmech.2017.10.020","article-title":"Recent advances in the search for novel 5-lipoxygenase inhibitors for the treatment of asthma","volume":"153","author":"Bruno","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114788_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0031-6865(94)90024-8","article-title":"5-Lipoxygenase: enzyme expression and regulation of activity","volume":"69","author":"Steinhilber","year":"1994","journal-title":"Pharm. Acta Helv."},{"issue":"1\u20133","key":"10.1016\/j.ejmech.2022.114788_bib23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejphar.2005.12.070","article-title":"Treatment of asthma with antileukotrienes: first line or last resort therapy?","volume":"533","author":"Dahl\u00e9n","year":"2006","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114788_bib24","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2796.2010.02246.x","article-title":"Microsomal prostaglandin E synthase-1 and 5-lipoxygenase: potential drug targets in cancer","volume":"268","author":"R\u00e5dmark","year":"2010","journal-title":"J. Intern. Med."},{"issue":"7","key":"10.1016\/j.ejmech.2022.114788_bib25","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1111\/j.1476-5381.2011.01707.x","article-title":"Molecular pharmacological profile of a novel thiazolinone-based direct and selective 5-lipoxygenase inhibitor","volume":"165","author":"Hofmann","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114788_bib26","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.ejmech.2018.05.041","article-title":"Structural insight into the optimization of ethyl 5-hydroxybenzo[g]indol-3-carboxylates and their bioisosteric analogues as 5-LO\/m-PGES-1 dual inhibitors able to suppress inflammation","volume":"155","author":"Bruno","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114788_bib27","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1517\/13543771003602012","article-title":"5-Lipoxygenase inhibitors: a review of recent developments and patents","volume":"20","author":"Pergola","year":"2010","journal-title":"Expert Opin. Ther. Pat."},{"issue":"13","key":"10.1016\/j.ejmech.2022.114788_bib28","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1055\/s-2007-990242","article-title":"Inhibition of 5-lipoxygenase product synthesis by natural compounds of plant origin","volume":"73","author":"Werz","year":"2007","journal-title":"Planta Med."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114788_bib29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2147\/NDS.S6410","article-title":"Nutritional benefits of flavocoxid in patients with osteoarthritis: efficacy and safety","volume":"2010","author":"Levy","year":"2010","journal-title":"Nutr. Diet. Suppl."},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2022.114788_bib30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0891-5849(98)00179-8","article-title":"Modulation of arachidonic acid metabolism by phenols: relation to their structure and antioxidant\/prooxidant properties","volume":"26","author":"Alanko","year":"1999","journal-title":"Free Radic. Biol. Med."},{"issue":"7\u20138","key":"10.1016\/j.ejmech.2022.114788_bib31","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1177\/106002809603000725","article-title":"Zileuton: the first 5-lipoxygenase inhibitor for the treatment of asthma","volume":"30","author":"Wenzel","year":"1996","journal-title":"Ann. Pharmacother."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114788_bib32","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1517\/14656566.2014.872241","article-title":"Leukotriene receptor antagonists pranlukast and montelukast for treating asthma","volume":"15","author":"Matsuse","year":"2014","journal-title":"Expet Opin. Pharmacother."},{"issue":"6","key":"10.1016\/j.ejmech.2022.114788_bib33","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2174\/138955711795843383","article-title":"Synthesis and cytotoxic activity of new \u03b2-carboline derivatives","volume":"11","author":"Peduto","year":"2011","journal-title":"Mini Rev. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114788_bib34","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ejmech.2010.11.028","article-title":"Structure-based design, synthesis and preliminary anti-inflammatory activity of bolinaquinone analogues","volume":"46","author":"Petronzi","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114788_bib35","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ejmech.2013.06.039","article-title":"Discovery and biological evaluation of novel 1,4-benzoquinone and related resorcinol derivatives that inhibit 5-lipoxygenase","volume":"67","author":"Filosa","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114788_bib36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1756-9966-32-24","article-title":"Cyclohexa-2,5-diene-1,4-dione-based antiproliferative agents: design, synthesis, and cytotoxic evaluation","volume":"32","author":"Petronzi","year":"2013","journal-title":"J. Exp. Clin. Cancer Res.: CR (Clim. Res.)"},{"key":"10.1016\/j.ejmech.2022.114788_bib37","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejmech.2015.02.042","article-title":"Novel series of benzoquinones with high potency against 5-lipoxygenase in human polymorphonuclear leukocytes","volume":"94","author":"Filosa","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114788_bib38","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bcp.2016.04.019","article-title":"The 5-lipoxygenase inhibitor RF-22c potently suppresses leukotriene biosynthesis in cellulo and blocks bronchoconstriction and inflammation in vivo","volume":"112","author":"Schaible","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114788_bib39","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ejmech.2016.10.046","article-title":"Optimization of benzoquinone and hydroquinone derivatives as potent inhibitors of human 5-lipoxygenase","volume":"127","author":"Peduto","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114788_bib40","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ejmech.2014.05.033","article-title":"Further studies on ethyl 5-hydroxy-indole-3-carboxylate scaffold: design, synthesis and evaluation of 2-phenylthiomethyl-indole derivatives as efficient inhibitors of human 5-lipoxygenase","volume":"81","author":"Peduto","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114788_bib41","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ejmech.2015.11.048","article-title":"Exploring the role of chloro and methyl substitutions in 2-phenylthiomethyl-benzoindole derivatives for 5-LOX enzyme inhibition","volume":"108","author":"Peduto","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114788_bib42","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.bcp.2013.04.015","article-title":"Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E\u2082 synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin","volume":"86","author":"Schaible","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114788_bib43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fphar.2020.00083","article-title":"Formulation and characterization of solid lipid nanoparticles loading RF22-c, a potent and selective 5-LO inhibitor, in a monocrotaline-induced model of pulmonary hypertension","volume":"11","author":"Liparulo","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"Pt A","key":"10.1016\/j.ejmech.2022.114788_bib44","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.phrs.2016.09.014","article-title":"Disodium cromoglycate inhibits asthma-like features induced by sphingosine-1-phosphate","volume":"113","author":"Roviezzo","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.ejmech.2022.114788_bib45","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/bph.13416","article-title":"Nociceptin\/orphanin FQ (N\/OFQ) modulates immunopathology and airway hyperresponsiveness representing a novel target for the treatment of asthma","volume":"173","author":"Singh","year":"2016","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114788_bib46","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1159\/000353427","article-title":"Effects of zileuton on airway smooth muscle remodeling after repeated allergen challenge in brown Norway rats","volume":"86","author":"Chen","year":"2013","journal-title":"Respiration; international review of thoracic diseases"},{"issue":"5","key":"10.1016\/j.ejmech.2022.114788_bib47","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/j.bmc.2009.01.045","article-title":"Plant extracts with anti-inflammatory properties--a new approach for characterization of their bioactive compounds and establishment of structure-antioxidant activity relationships","volume":"17","author":"Amaral","year":"2009","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114788_bib48","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1749-8546-7-26","article-title":"Antioxidant and anti-inflammatory activities of selected medicinal plants and fungi containing phenolic and flavonoid compounds","volume":"7","author":"Diaz","year":"2012","journal-title":"Chin. Med."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114788_bib49","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0090-6980(85)90006-1","article-title":"Intraperitoneal injection of zymosan in mice induces pain, inflammation and the synthesis of peptidoleukotrienes and prostaglandin E2","volume":"30","author":"Doherty","year":"1985","journal-title":"Prostaglandins"},{"issue":"2","key":"10.1016\/j.ejmech.2022.114788_bib50","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1139\/y95-028","article-title":"Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist","volume":"73","author":"Jones","year":"1995","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114788_bib51","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0090-6980(83)90104-1","article-title":"Inflammation and pain sensitivity: effects of leukotrienes D4, B4 and prostaglandin E1 in the rat paw","volume":"25","author":"Rackham","year":"1983","journal-title":"Prostaglandins"},{"issue":"11","key":"10.1016\/j.ejmech.2022.114788_bib52","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1002\/ajoc.202000443","article-title":"Palladium-catalyzed direct C\u2212H arylation of arenes promoted by quaternary ammonium salt","volume":"9","author":"Yang","year":"2020","journal-title":"Asian J. Org. Chem."},{"issue":"66","key":"10.1016\/j.ejmech.2022.114788_bib53","doi-asserted-by":"crossref","first-page":"10163","DOI":"10.1039\/C6CC05078F","article-title":"Dual gold photoredox C(sp2)\u2013C(sp2) cross couplings \u2013 development and mechanistic studies","volume":"52","author":"Gauchota","year":"2016","journal-title":"Chem. Commun."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114788_bib54","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1021\/tx00043a012","article-title":"A new strategy for the synthesis of polychlorinated biphenyl metabolites","volume":"8","author":"Bauer","year":"1995","journal-title":"Chem. Res. Toxicol."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114788_bib55","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/ajoc.202000059","article-title":"A combination of biocompatible room temperature ionic liquid and palladium catalyst for base\u2010 and ligand\u2010free Suzuki coupling reactions","volume":"9","author":"Joo","year":"2020","journal-title":"Asian Journal of Organic Chemistry"},{"key":"10.1016\/j.ejmech.2022.114788_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104616","article-title":"Synthesis and in vitro study of nitro- and methoxy-2-phenylbenzofurans as human monoamine oxidase inhibitors","volume":"107","author":"Delogu","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2022.114788_bib57","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.tetlet.2017.01.089","article-title":"Mono- and dinuclear cyclopalladates as catalysts for Suzuki\u2013Miyaura cross-coupling reactions in predominantly aqueous media","volume":"58","author":"Babu","year":"2017","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2022.114788_bib58","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.1039\/C4DT01574F","article-title":"Synthesis, magnetic properties and dynamic behavior of cobalt complexes with an anthracene-containing dioxolene ligand","volume":"43","author":"Katayama","year":"2014","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2022.114788_bib59","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1016\/j.tet.2017.01.061","article-title":"Synthesis of \u03b1-oxygenated ketones and substituted catechols via the rearrangement of N-enoxy- and N-aryloxyphthalimides","volume":"73","author":"Kroc","year":"2017","journal-title":"Tetrahedron"},{"issue":"1","key":"10.1016\/j.ejmech.2022.114788_bib60","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1139\/m76-014","article-title":"The in vitro hydroxylation of 4\u2032-chloro-4-biphenylol by a mushroom tyrosinase preparation","volume":"22","author":"Safe","year":"1976","journal-title":"Can. J. Microbiol."},{"issue":"37","key":"10.1016\/j.ejmech.2022.114788_bib61","doi-asserted-by":"crossref","first-page":"12271","DOI":"10.1021\/jacs.6b07269","article-title":"Conversion of simple cyclohexanones into catechols","volume":"138","author":"Liang","year":"2016","journal-title":"J. Am. Chem. Soc."},{"issue":"26","key":"10.1016\/j.ejmech.2022.114788_bib62","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1016\/S0040-4020(01)00462-8","article-title":"An expeditious synthesis of polyhydroxylated 2-arylbenzo[b]furans","volume":"57","author":"Dupont","year":"2001","journal-title":"Tetrahedron"},{"issue":"25","key":"10.1016\/j.ejmech.2022.114788_bib63","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1016\/j.tetlet.2006.04.027","article-title":"An expeditious aqueous Suzuki\u2013Miyaura method for the arylation of bromophenols","volume":"47","author":"Freundlich","year":"2006","journal-title":"Tetrahedron Lett."},{"issue":"7","key":"10.1016\/j.ejmech.2022.114788_bib64","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"13","key":"10.1016\/j.ejmech.2022.114788_bib65","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1111\/bph.12955","article-title":"Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP","volume":"172","author":"McGrath","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114788_bib66","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/cea.12808","article-title":"Nociceptin reduces the inflammatory immune microenvironment in a conventional murine model of airway hyperresponsiveness","volume":"47","author":"Spaziano","year":"2017","journal-title":"Clin. Exp. Allergy: journal of the British Society for Allergy and Clinical Immunology"},{"issue":"10","key":"10.1016\/j.ejmech.2022.114788_bib67","doi-asserted-by":"crossref","first-page":"L657","DOI":"10.1152\/ajplung.00358.2012","article-title":"Nociceptin\/orphanin FQ receptor activation decreases the airway hyperresponsiveness induced by allergen in sensitized mice","volume":"304","author":"Sullo","year":"2013","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114788_bib68","first-page":"25","article-title":"Use of free radical method to evaluate antioxidant activity","volume":"28","author":"Brand-Williams","year":"1995","journal-title":"Food Sci. Technol."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114788_bib69","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/abio.1996.0292","article-title":"The ferric reducing ability of plasma (FRAP) as a measure of \"antioxidant power\": the FRAP assay","volume":"239","author":"Benzie","year":"1996","journal-title":"Anal. Biochem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422006900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422006900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:53:12Z","timestamp":1759330392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422006900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":69,"alternative-id":["S0223523422006900"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114788","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of functionalized 4-aryl-Catechol derivatives as new antiinflammtory agents with in vivo efficacy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114788","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"114788"}}